Ed Dudley

Dr Ed Dudley is an Associate Professor in Biomedical Sciences at Swansea University's Faculty of Medicine, Health and Life Science. He serves as Programme Director for BSc/MSci Biochemistry degrees and specializes in analytical biochemistry with a focus on biomarker discovery using proteomic and metabolomic techniques. His research explores urinary nucleosides as cancer biomarkers, psychiatric disorder profiling, and optimization of mass spectrometry methods. He contributes to interdisciplinary themes in medical biomarkers and device technology.

Research Interests: His work spans advanced mass spectrometry applications, biomarker validation in diseases (e.g., cancer, schizophrenia), protein/nucleoside profiling, and development of diagnostic tools. His expertise includes metabolomics, proteomics, bioanalytical chemistry, and clinical diagnostics. Recent studies include antimicrobial peptide cytotoxicity, maggot therapy mechanisms, and pharmacovigilance analysis of veterinary drug misuse in humans.

Publications: His 150+ publications emphasize biomarker discovery and analytical techniques. Notable works include metabolomic approaches for schizophrenia biomarkers, proteomic profiling in autism, and antimicrobial peptide studies in cancer cells. Recent trends focus on interdisciplinary applications like taurine supplementation in thermoregulation and veterinary drug misuse analysis.

Professional Contributions: He supervises PhD/MSc students in biomarker research, antimicrobial development, and veterinary medicine impacts. Teaches modules on biochemistry, molecular techniques, and medical research skills. Collaborates with clinical and industrial partners in diagnostic technology and drug discovery.

Labs/Teams: Active in Swansea University Medical School's biomarkers and genes research theme, collaborating with the Morgan Advanced Studies Institute (MASI) and clinical departments. Engages in multidisciplinary projects combining proteomics, metabolomics, and clinical diagnostics.